Mucormycosis is a difficult to diagnose rare disease with high morbidity and mortality.
Diagnosis is often delayed, and disease tends to progress rapidly. Urgent surgical and …

Mucormycosis is an infection caused by a group of filamentous molds within the order
Mucorales. Infections may result from ingestion of contaminated food, inhalation of spores …

Purpose: To report two cases of COVID-19 under treatment with a corticosteroid; in one case
rhino-orbitocerebral mucormycosis and in another one rhino-orbital mucormycosis …

The European Conference on Infections in Leukemia (ECIL) provides recommendations for
diagnostic strategies and prophylactic, pre-emptive or targeted therapy strategies for various …

Background Mucormycosis is an uncommon invasive fungal disease with high mortality and
few treatment options. Isavuconazole is a triazole active in vitro and in animal models …

Invasive mucormycosis is a life-threatening fungal infection that most frequently occurs in
patients with underlying comorbidities impacting immune system function. 1–4 Rhino-orbital …

Abstract These European Society for Clinical Microbiology and Infectious Diseases and
European Confederation of Medical Mycology Joint Clinical Guidelines focus on the …

Despite the recent introduction of mold-active agents (posaconazole and isavuconazole), in
addition to amphotericin B products, to our armamentarium against mucormycosis, many …

The incidence of invasive mycoses is increasing, especially among patients who are
immunocompromised or hospitalized with serious underlying diseases. Such infections may …

Isavuconazole is a new extended-spectrum triazole with activity against yeasts, molds, and
dimorphic fungi. It is approved for the treatment of invasive aspergillosis and mucormycosis …